[Hepatocellular Carcinoma--epidemiology and Treatment]
Overview
Public Health
Authors
Affiliations
Hepatocellular carcinoma (HCC) is one of the most commonly occurring solid tumors worldwide and is the most frequent cause of cancer death in some parts of the world such as China and sub-Saharan Africa. HCC appears to be rising dramatically in incidence in developed western countries too. The most frequent underlying factors causing HCC are chronic viral hepatitis and cirrhosis. Early detection of HCC is a key factor in improving outcomes of therapies. There is growing evidence that HCC may be prevented with strategies aimed at preventing or treating viral hepatitis. Surgery, including liver transplantation, remains the most efficient treatment but only for 15-30% of patients. Recent developments suggest that other therapeutic modalities such as loco-regional (ablative) methods are also potentially curative.
Effect of Lipopolysaccharides on Liver Tumor Metastasis of Double Transgenic Zebrafish.
Lu J, Lin L, Sun Y, Liu D, Gong Z Biomedicines. 2022; 10(1).
PMID: 35052775 PMC: 8773574. DOI: 10.3390/biomedicines10010095.
Morishita A, Tani J, Nomura T, Takuma K, Nakahara M, Oura K Cancers (Basel). 2021; 13(18).
PMID: 34572832 PMC: 8468113. DOI: 10.3390/cancers13184605.
MicroRNA-361-5p Inhibits Tumorigenesis and the EMT of HCC by Targeting Twist1.
Yin L, Xiao G, Zhou R, Huang X, Li N, Tan C Biomed Res Int. 2020; 2020:8891876.
PMID: 33381597 PMC: 7762665. DOI: 10.1155/2020/8891876.
Cai S, Bai Y, Wang H, Zhao Z, Ding X, Zhang H J Exp Clin Cancer Res. 2020; 39(1):135.
PMID: 32669125 PMC: 7362638. DOI: 10.1186/s13046-020-01634-7.
The epidemiology of hepatocellular cancer in Poland.
Wasiak D, Pliszczynski J, Lagiewska B, Jonas M, Panczyk M, Malkowski P Clin Exp Hepatol. 2018; 4(1):13-27.
PMID: 29594194 PMC: 5865910. DOI: 10.5114/ceh.2018.73669.